Confidentiality; Publicity All written information marked as confidential and exchanged between WFH and Ortho while this Agreement is in effect shall be treated as confidential information unless one of the exceptions set out below applies. The party receiving such confidential information shall not, for so long as that information retains its character as confidential information, use (other than in the performance of its obligations or the exercise of its rights hereunder) or disclose such information to any third party (except any Affiliates or those consultants of the receiving party that have an obligation of confidentiality to the receiving party) without the prior written approval of the disclosing party. Information will be deemed nonconfidential at such time as such information either has become public knowledge through no fault of the party receiving such information, or comes to such party from a third party under no obligation of confidentiality with respect to such information or was in the possession of such party prior to the date of disclosure, or is developed by or on behalf of such party without any reliance on confidential information received hereunder or is otherwise required to be disclosed in compliance with an order by a court or other regulatory body having competent jurisdiction. The obligations of the parties set forth in this Section shall survive termination of this Agreement until the third anniversary of the effective date of such termination. Upon termination of this Agreement, all Confidential Information of a disclosing party that is held by a receiving party shall be returned to the disclosing party except that one copy of such Confidential Information shall be retained by counsel for the receiving party to ensure compliance with this Section. Neither party shall originate any publicity, news release or public announcement, written or oral, whether to the public or press, stockholders or otherwise, relating to this Agreement, to any amendment or performances under the Agreement, without the prior written consent of the other which consent shall not be unreasonably withheld, except for such announcements as in the opinion of counsel for the party making such announcement is required by law to be made. If a party decides to make an additional announcement required by law under this Agreement, it shall give the other party thirty (30) days advance written notice, or any shorter notice period otherwise required by law, of the text of the announcement so that the other party shall have an opportunity to comment upon the announcement.
CONFIDENTIALITY AND PUBLICITY 9.1 Supplier will keep the existence, nature and the content of the Agreement, Accenture Data (as defined in Section 14.1), and any other information of Accenture, confidential and not disclose it to any other person. Supplier will ensure that its personnel, contractors and agents (collectively, “Personnel”) are aware of, and have committed to, confidentiality and legal obligations with respect to such information. Supplier will not make any reference to the Agreement, its terms, business information, or use Accenture’s name, logo or trademark in any public announcements, promotions or any other communication without Accenture’s prior written consent.
Confidentiality and Publication 4.1 Any information which is disclosed by Xxxxxxx to the Recipient or the Recipient Scientist in connection with the Research Project and/or the Original Material ("Confidential Information") shall remain confidential to, and the property of, Xxxxxxx. The Recipient and the Recipient Scientist hereby agree that for so long as the Confidential Information remains confidential in nature, the Recipient and the Recipient Scientist shall keep the Confidential Information secret. Upon request, the Recipient shall inform Xxxxxxx and the Xxxxxxx Scientist on the status of its research. The Recipient Scientist will inform Xxxxxxx at least 30 days in advance of the submission of any potential publication of any form (abstract, manuscript, review, oral presentation, patent application etc.) related to the use of the Material and/or Modifications or the Research Project. If Xxxxxxx believes that co-authorship is required, Xxxxxxx and Recipient Scientist shall discuss in good faith co-authorship of all oral or written publications. If Xxxxxxx does not require co-authorship, the Recipient Scientist shall acknowledge Xxxxxxx and Xxxxxxx Scientist as the source of the Material in all publications reporting use of the Material and/or Modifications. The Recipient Scientist shall reference the following publication(s) in all publications reporting the use of the Material: Xxxxxx J; Xxxxxxx L, Xxxxxxxx H, Xxxxxxxxxxxx S, Xxxxxxxx E, Xxxxxxxx D, Xxxxxxx G (1991). "Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis." EMBO J.; 10(13); 4025-31. If Xxxxxxx believes that the publication contains any Confidential Information it shall so notify the Recipient Scientist. Recipient shall proceed to implement the amendments requested by Xxxxxxx including the removal of any Confidential Information, with every effort made so that such amendments made will not compromise the timing nor the scientific value of the publication or presentation.
Confidentiality & Proprietary Information The Consultant acknowledges that it will be necessary for the Client to disclose certain confidential and proprietary information to the Consultant in order for the Consultant to perform their duties under this Agreement. The Consultant acknowledges that disclosure to a third (3rd) party or misuse of this proprietary or confidential information would irreparably harm the Client. Accordingly, the Consultant will not disclose or use, either during or after the term of this Agreement, any proprietary or confidential information of the Client without the Client's prior written permission except to the extent necessary to perform the Services on the Client's behalf. Proprietary or confidential information includes, but is not limited to:
Confidentiality of Client Information ENP providers shall ensure that information about, or obtained from a participant’s records, shall be maintained in a confidential manner.
MPS LOGO/PUBLICITY No Contractor shall use the MPS Logo in its literature or issue a press release about the subject of this Contract without prior written notice to and written approval of MPS’s Executive Director of Communications & Outreach.
– PUBLICITY / CONFIDENTIALITY 11.1 No news releases, public announcements, advertising materials, or confirmation of same, concerning any part of this Agreement or any Purchase Order issued hereunder shall be issued or made without the prior written approval of the Parties. Neither Party shall in any advertising, sales materials or in any other way use any of the names or logos of the other Party without the prior written approval of the other Party.